Patient Portal    LOGIN    NEW USER 💳   Pay Bill
[wd_asp id=1]
COVID-19 Monoclonal Antibodies

NOW OFFERING
COVID-19 Monoclonal Antibodies

 

Middletown Medical is proud to now offer monoclonal antibody treatments for COVID-19 patients. Early monoclonal antibody treatment has been proven to prevent hospitalization and reduce the risk of death. Recommended treatment is within 72-hours of COVID-19 diagnosis, and patients should inquire about treatment as soon as they receive a positive result. However, treatment can be given up to 10 days post-diagnosis.

Monoclonal antibodies are currently the only recognized treatment for COVID-19 to prevent hospitalization.

Middletown Medical’s standard charge for this cutting-edge therapy is $2,250.

CLICK HERE TO REQUEST A TELEMEDICINE APPOINTMENT
TO VERIFY YOUR ELIGIBILITY.

*Schedule Appointment

Or, contact us to learn more: 845.342.4774

What are monoclonal antibodies?

Monoclonal antibodies are laboratory-produced molecules that act as substitute antibodies that can restore, enhance or mimic the immune system’s attack on cells.

How do monoclonal antibodies treat COVID-19?

Monoclonal antibodies for COVID-19 may block the virus that causes COVID-19 from attaching to human cells, making it more difficult for the virus to reproduce and cause harm. Monoclonal antibodies may also neutralize a virus.

How do I receive the treatment?

Monoclonal antibody treatments for COVID-19 are only administered in settings in which healthcare providers have immediate access to medications to treat a severe infusion reaction, such as anaphylaxis, and have the ability to activate the emergency medical system (EMS).

Middletown Medical’s Infusion Center features the latest in infusion treatment technology and has a specialized team to monitor your care during the antibody treatment.

Pin It on Pinterest